Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04162132 · ClinicalTrials.gov registry record
Contingency Management Using Smartphone App in Patients With SUD
A clinical trial of Substance Use Disorders, sponsored by BrightView.
- Completed
- Registry status
- 108
- Enrollment target
- 1
- Study location
NCT04162132: Completed study of Substance Use Disorders, sponsored by BrightView.
NCT04162132 is a study of Substance Use Disorders that has completed, run by BrightView. The registered enrollment target is 108 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04162132, a study of Substance Use Disorders, has completed, sponsored by BrightView.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the acceptance and efficacy of a smartphone app (DynamiCare Rewards) for patients with substance use disorder (SUD) who are in active treatment and recovery at BrightView.
Primary Outcome
The DynamiCare smart phone app was used to see whether the percentage of scheduled appointments could be increased by using the app. As measured by % of attendance of medical and clinical appointments compared to controls.
Conditions Studied
Interventions
- DEVICE Smartphone app
Study Locations (1)
Ohio
- BrightView - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2019-01-25 |
| Est. Completion | 2019-07-29 |
What the finished NCT04162132 record still lists
NCT04162132 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Smartphone app is the first listed.
NCT04162132 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04162132 about?
NCT04162132 is a clinical study titled "Contingency Management Using Smartphone App in Patients With SUD". The purpose of this research study is to test the acceptance and efficacy of a smartphone app (DynamiCare Rewards) for patients with substance use disorder (SUD) who are in active treatment and recovery at BrightView.
What is the current status of trial NCT04162132?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2019-01-25. Estimated completion is 2019-07-29.
What conditions does trial NCT04162132 study?
This clinical trial studies the following conditions: Substance Use Disorders.
What interventions are being tested in trial NCT04162132?
The interventions under investigation include: Smartphone app (DEVICE).
Who is sponsoring clinical trial NCT04162132?
This trial is sponsored by BrightView, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04162132 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04162132's enrollment target sits among peer trials
108 50th of 93 higher than 44 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI